Publications by authors named "Luis A Clavell"

Claim this Profile
O
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia.
Elena J Ladas, Haiyang Sheng, Uma H Athale, Barbara L Asselin, Luis A Clavell

JAMA Netw Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012-2016.
Ingrid M Montes-Rodríguez, Marievelisse Soto-Salgado, Carlos R Torres-Cintrón, Jonnalie C Tomassini-Fernandini, Erick Suárez, Luis A Clavell

Cancer Epidemiol Biomarkers Prev· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
Uma H Athale, Yael Flamand, Traci Blonquist, Kristen E Stevenson, Menachem Spira, Luis A Clavell

Pediatr Blood Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001.
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, Jeffrey G Supko, Sarah K Hunt, Luis A Clavell

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum.
Melissa A Burns, Andrew E Place, Kristen E Stevenson, Alejandro Gutiérrez, Suzanne Forrest, Luis A Clavell

Pediatr Blood Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
Melissa A Burns, Andrew E Place, Kristen E Stevenson, Alejandro Gutiérrez, Suzanne Forrest, Luis A Clavell

Pediatr Blood Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort.
Song Yao, Qianqian Zhu, Peter D Cole, Kristen Stevenson, Marian H Harris, Luis A Clavell

Blood Adv· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT Cohort.
Elena J Ladas, Traci M Blonquist, Maneka Puligandla, Manuela Orjuela, Kristen Stevenson, Luis A Clavell

J Clin Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort.
Elena J Ladas, Manuela Orjuela, Kristen Stevenson, Peter D Cole, Meiko Lin, Luis A Clavell

Clin Nutr· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Uma H Athale, Maneka Puligandla, Kristen E Stevenson, Barbara Asselin, Luis A Clavell

Pediatr Blood Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to comment on: Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
Maria Luisa Sulis, Traci M Blonquist, Kristen E Stevenson, Sarah K Hunt, Samantha Kay-Green, Luis A Clavell

Pediatr Blood Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001.
Lynda M Vrooman, Traci M Blonquist, Marian H Harris, Kristen E Stevenson, Andrew E Place, Luis A Clavell

Blood Adv· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.
Justine M Kahn, Peter D Cole, Traci M Blonquist, Kristen Stevenson, Zhezhen Jin, Luis A Clavell

Pediatr Blood Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.
Thai Hoa Tran, Marian H Harris, Jonathan V Nguyen, Traci M Blonquist, Kristen E Stevenson, Luis A Clavell

Blood Adv· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic.
Justine M Kahn, Uma H Athale, Luis A Clavell, Peter D Cole, Jean-Marie Leclerc

J Pediatr Health Care· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study.
Elena J Ladas, Manuela Orjuela, Kristen Stevenson, Peter D Cole, Meiko Lin, Luis A Clavell

Nutrition· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Andrew E Place, Kristen E Stevenson, Lynda M Vrooman, Marian H Harris, Sarah K Hunt, Luis A Clavell

Lancet Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.
Steven E Lipshultz, Stuart R Lipsitz, Jeffery L Kutok, Tracie L Miller, Steven D Colan, Luis A Clavell

Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, Jane O'Brien, Suzanne E Dahlberg, Luis A Clavell

J Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes.
Steven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, Donna S Neuberg, Suzanne E Dahlberg, Luis A Clavell

Pediatrics· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
Steven E Lipshultz, Tracie L Miller, Rebecca E Scully, Stuart R Lipsitz, Nader Rifai, Luis A Clavell

J Clin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial.
Steven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, Stephen E Sallan, Lewis B Silverman, Luis A Clavell

Lancet Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
Elly V Barry, Lynda M Vrooman, Suzanne E Dahlberg, Donna S Neuberg, Barbara L Asselin, Luis A Clavell

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
Elly Barry, Daniel J DeAngelo, Donna Neuberg, Kristen Stevenson, Mignon L Loh, Luis A Clavell

J Clin Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
Steven E Lipshultz, Nader Rifai, Virginia M Dalton, Donna E Levy, Lewis B Silverman, Luis A Clavell

N Engl J Med· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis